MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2025 International Congress

    Psychometric Properties of the SCOPA-Cog Turkish version

    S. Isazade, H. Ozden, D. Gunal (Istanbul, Turkey)

    Objective: The objective of this study is to adapt SCOPA-COG for Turkish-speaking patients with Parkinson's disease, ensuring it is both valid and reliable. This will…
  • 2025 International Congress

    Mortality Trends Associated with Parkinson’s Disease with Diabetes Mellitus in the United States (1999-2020)

    T. Patel, R. Khan, M. Athar, S. Aleem, A. Khan, M. Altaf, A. Khan, M. Shahabi, B. Aslam, E. Zulfiqar, R. Millis, A. Awosika (Kingstown, Saint Vincent and the Grenadines)

    Objective: To assess the mortality trends and disparities associated with Parkinson’s disease in diabetic patients in the U.S. Background: Parkinson's disease (PD) is the second…
  • 2025 International Congress

    Critical appraisal of MDS Criteria for diagnosing PD

    S. Fox, . , . (Toronto, Canada)

    Objective: To determine the validity of MDS Diagnostic criteria for PD by assessing individual diagnostic criteria in pathologically confirmed PD Background: The 2015 MDS criteria…
  • 2025 International Congress

    Retrospective Analysis of the Neuropsychological Profiles of Parkinson’s Disease Patients Selected for Deep Brain Stimulation Surgery in Hawaii.

    E. Krening, A. Ford, M. Bruno, T. Umaki (Honolulu, USA)

    Objective: To investigate the neuropsychological profiles of White, Japanese, and other Asian American or Pacific Islander (OAAPI) patients with Parkinson’s disease (PD) identified as candidates…
  • 2025 International Congress

    The PDCogniCare Toolkit: Developing a harmonised neuropsychological toolkit specific to Parkinson’s Disease

    E. Mccann, D. Pourzinal, D. Sriram, L. Mitchell, J. Liddle, A. Lehn, N. Dissanayaka (Herston, Australia)

    Objective: To critically evaluate neuropsychological measures predictive of cognitive decline in Parkinson’s disease (PD) with the aim of proposing a comprehensive, evidence-based neuropsychological toolkit specific…
  • 2025 International Congress

    Impact of Genetically Defined Ancestry on Progression of Idiopathic Parkinson’s Disease.

    J. Frost, S. Gray-Rodriguez, L. Wu, M. Lawton, Y. Ben-Shlomo, M. Hu, D. Grosset, R. Real, H. Morris (London, United Kingdom)

    Objective: To assess the impact of genetically defined ancestry on progression of idiopathic Parkinson's Disease and evaluate the contribution of known genetic variation on any…
  • 2025 International Congress

    Anti-Parkinsonian effects of Globimetula cupulata leaf extract and its underlying mechanisms in 6-hydroxydopamine-lesioned rat model

    A. Hamadjida, R. Ayissi Mbomo, S. Minko, F. Ntchapda, J. Mingoas Kilekoung (BERTOUA, Cameroon)

    Objective: To evaluate the neuroprotective effects of Globimetula cupulata in a rat model of Parkinson Disease (PD) induced by 6-hydroxydopamine (6-OHDA) injection in the striatum,…
  • 2025 International Congress

    Daily Activity Analysis of Parkinson’s Disease Using Machine Learning with 3D Poses

    KD. Kim, S. Lyu, T. Dunn (Durham, USA)

    Objective: This study aims to find a digital behavioral marker Parkinson’s disease (PD) in activities of daily living via machine learning (ML) analysis of 3D…
  • 2025 International Congress

    Early Indicators of Alpha-synuclein Aggregation: Can Autonomic and Cognitive Markers Predict Prodromal Parkinson’s Disease?

    B. Kansu, C. Mattjie, R. Ravazio, M. Patyjewicz, A. Noyce, C. Simonet (London, United Kingdom)

    Objective: To develop a model that predicts alpha synuclein (a-syn) status of patients at risk of Parkinson’s disease (PD) using non-motor and cognitive tests that…
  • 2025 International Congress

    Parkinson disease subtype stability and eventual convergence

    H. Lessov-Schlaggar, A. Eid, T. Cash, E. Foster, B. Maiti, H. Hwang, R. Perrin, P. Kotzbauer, J. Perlmutter, M. Campbell (Saint Louis, USA)

    Objective: To determine the longitudinal stability of Parkinson disease (PD) subtype membership. Background: Previous research demonstrates distinct PD subtypes of “motor only”, “psychiatric & motor”,…
  • « Previous Page
  • 1
  • …
  • 162
  • 163
  • 164
  • 165
  • 166
  • …
  • 1734
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • AI-Powered Detection of Freezing of Gait Using Wearable Sensor Data in Patients with Parkinson’s Disease
  • To be or not to bupropion: a drug-induced parkinsonism?
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Insulin dependent diabetes and hand tremor
  • Improvement in hand tremor following carpal tunnel release surgery
  • Impact of expiratory muscle strength training (EMST) on phonatory performance in Parkinson's patients
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley